Kisqali 200 MG daily dose UU 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FM6F9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,166
Award facts
- Contract value 100% obligated
- $18,165.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,165.88 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Kisqali 200 mg daily dose in 21-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by December 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the federal government.
This contract is a child order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Kisqali order supports DLA's medical supply chain requirements for oncology treatment, consistent with the company's extensive portfolio of specialty medications and brand-name pharmaceuticals delivered through competitive federal contracts.
Quick answers
Who was awarded contract SPE2DR26FM6F9?
SPE2DR26FM6F9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FM6F9 worth?
The government has obligated $18,166 on SPE2DR26FM6F9.
Is contract SPE2DR26FM6F9 an order under another contract?
Yes. SPE2DR26FM6F9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6F9 competed?
The extent of competition for SPE2DR26FM6F9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award